Sign in

CIK 0000025743

  • Non-accelerated filer
  • Smaller reporting company

TherapeuticsMD, Inc.

Sign in to watch
Ticker
TXMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
870233535
Phone
+1 561-961-1900
Business address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
Former names
AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale Chief Strategy Officer sold 300,000 shares at $2.26 ($676,920)
  3. 4 Open-market buy President/Secretary bought 72,000 shares at $2.75 ($198,000)
  4. 4 Open-market buy President/Secretary bought 72,000 shares at $2.75 ($198,000)
  5. 4 Open-market buy Director bought 36,000 shares at $2.75 ($99,000)
  6. 4 Open-market buy CEO bought 72,000 shares at $2.75 ($198,000)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Director bought 10,000 shares at $2.77 ($27,700)
  14. 4 Open-market buy CEO bought 35,000 shares at $2.74 ($95,900)
  15. 4 Open-market buy President/Secretary bought 10,000 shares at $2.93 ($29,300)
  16. 4 Open-market buy Director bought 35,000 shares at an average $2.83 ($98,900)
  17. 4 Open-market buy Director bought 3,144 shares at $3.18 ($9,998)
  18. 4 Open-market buy President/Secretary bought 15,000 shares at $3.16 ($47,400)
  19. 4 Open-market buy Director bought 5,000 shares at $3.04 ($15,200)
  20. 4 Open-market buy Director bought 10,000 shares at $2.87 ($28,700)

Page 8 of 22 · 428 filings